piracetam has been researched along with Chronic Kidney Diseases in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam is a frequently used drug in the therapy of partial onset, myoclonic and generalized tonic-clonic seizures." | 3.80 | A missed opportunity - consequences of unknown levetiracepam pharmacokinetics in a peritoneal dialysis patient. ( Bahte, SK; Hiss, M; Kielstein, JT; Lichtinghagen, R, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahte, SK | 1 |
| Hiss, M | 1 |
| Lichtinghagen, R | 1 |
| Kielstein, JT | 1 |
1 other study available for piracetam and Chronic Kidney Diseases
| Article | Year |
|---|---|
A missed opportunity - consequences of unknown levetiracepam pharmacokinetics in a peritoneal dialysis patient.
Topics: Aged; Anticonvulsants; Fatigue; Humans; Levetiracetam; Male; Metabolic Clearance Rate; Peritoneal Di | 2014 |